Stocksplit, thanks for posting that. Do you know a direct link for that info on sinofresh.com?
I just checked and don't see it there. Then again, the home page still says, "SinoFresh HealthCare, Inc. SFSH.PK is a publicly traded company," so maybe they probably aren't springing for a web dev consultant to update their site regularly.
Assuming this is accurate info, my takeaway is:
-- Company ran out of cash.
-- They can't afford to finish the audits without cash, let alone paying for SEC filings and soliciting MMs. So the stock remains in delisted until finances improve.
-- Without new 3rd-party financing, they can't launch their new products.
If so, there are two ways forward here:
1. Existing product, Sinofresh, gains traction, increasing revenue, providing capital to launch the new products and resuming auditing and stock filing. This seems unlikely without a marketing campaign, but given the strong customer reviews, might happen over time due to word-of-mouth during a winter flu season.
2. The company finds some deep pockets or VC that like the product and fund the next stage of evolution. Olund filled this role for a bit, but evidently he is tapped out now.
Note that if we do get new financing, we will face some manner of significant dilution, so the new investors get a stake in the company. So there's a decent chance our current holdings will be diluted to minutia. So goes in pinks. A good example of why it's better to ante a toehold on speculative potential, waiting for tangible success before jumping in with both feet.
In the meantime, with the stock delisted, we can't buy or sell anyway, so are better off focusing on other stocks, enjoying summer, and just keeping tabs on this periodically.
Market Data 
Markets 
AI
